Published 2022 | Version v1
Publication

Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: Data from an early-access program in Italy

Additional details

Identifiers

URL
https://hdl.handle.net/11567/1169595
URN
urn:oai:iris.unige.it:11567/1169595

Origin repository

Origin repository
UNIGE